Arkolith/Insider Trading/ASND/Form 4

Jensen Flemming Steen

See RemarksAscendis Pharma A/S (ASND) · full profile →Form 4 · filed May 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.6M
Net Open-Market Flow
-$4.6M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Sell(S)19K$238.49$4.6M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML